Abstract
Purpose
Batten disease or neuronal ceroid lipofuscinosis is the most prevalent neurodegenerative disorder of childhood. Previously reported perioperative complications in children with Batten disease have come mainly from single case reports. The primary aim of the current study was to investigate perioperative complications of patients with Batten disease in the largest cohort known to date. The secondary objective was to characterize the anesthetic management including the use of propofol and to assess its association with adverse events.
Method
We conducted a single center, retrospective descriptive study by querying the hospital’s electronic medical record to identify patients with a diagnosis of Batten disease or ICD10 E75.4 who received anesthetic care from December 2014 to May 2019.
Results
Thirty-five patients who underwent a total of 93 anesthetic encounters (range 1–11) were included in the analysis. A total of 29 adverse events were identified. Hypotension (N = 6, 6.5%) and bradycardia (N = 7, 7.5%) requiring treatment with medications were the most common adverse events. Other adverse events include oxygen desaturation (N = 4, 4.3%), seizures (N = 4, 4.3%), unanticipated hospital or ICU admission (N = 1, 1.1%), PACU phase 1 stay > 120 min (N = 2, 2.2%), hypothermia (N = 4, 4.3%), agitation (N = 1, 1.1%), and laryngospasm requiring treatment (N = 1, 1.1%). The number of preoperative anti-epileptic drugs (AEDs) had a positive correlation with the rate of perioperative adverse events. There was no statistical relationship of adverse events with intraoperative use of propofol (odds ratio 1.03, 95% CI 0.42–2.51).
Conclusions
The majority of these patients were managed without clinically significant perioperative complications. As previously reported, bradycardia, hypotension, and hypothermia were the most common adverse events. Routine avoidance of propofol in patients with Batten disease does not appear warranted.
Similar content being viewed by others
References
Nita DA, Mole SE, Minassian BA. Neuronal ceroid lipofuscinoses. Epileptic Disord. 2016;18:73–88.
Schulz A, Kohlschutter A, Mink J, Simonati A, Williams R. NCL diseases—clinical perspectives. Biochim Biophys Acta. 2013;1832:1801–6.
Williams RE, Mole SE. New nomenclature and classification scheme for the neuronal ceroid lipofuscinoses. Neurology. 2012;79:183–91.
Yamada Y, Doi K, Sakura S, Saito Y. Anesthetic management for a patient with Jansky–Bielschowsky disease. Can J Anaesth. 2002;49:81–3.
Kako H, Martin DP, Tobias JD. Perioperative care of a patient with neuronal ceroid lipofuscinoses. Saudi J Anaesth. 2013;7:336–40.
Hiramori T, Goto S, Kuroiwa K, Mochizuki N, Takano T, Kawakami K, Nishizawa M. Anesthetic management of patients with neuronal ceroid lipofusucinosis. Masui. 2011;60:1207–10.
Miao N, Levin SW, Baker EH, Caruso RC, Zhang Z, Gropman A, Koziol D, Wesley R, Mukherjee AB, Quezado ZM. Children with infantile neuronal ceroid lipofuscinosis have an increased risk of hypothermia and bradycardia during anesthesia. Anesth Analg. 2009;109:372–8.
Defalque RJ. Anesthesia for a patient with Kufs' disease. Anesthesiology. 1990;73:1041–2.
Finsterer J, Frank M. Propofol Is mitochondrion-toxic and may unmask a mitochondrial disorder. J Child Neurol. 2016;31:1489–94.
Fleming S, Thompson M, Stevens R, Heneghan C, Pluddemann A, Maconochie I, Tarassenko L, Mant D. Normal ranges of heart rate and respiratory rate in children from birth to 18 years of age: a systematic review of observational studies. Lancet. 2011;377:1011–8.
Syed F, Uffman J, Tumin D, Flaitz C, Tobias J, Raman V. A study on the efficacy and safety of combining dental surgery with tonsillectomy in pediatrics. Clin Cosmetic Investig Dentistry. 2018;10:45–9.
Miketic RM, Uffman J, Tumin D, Tobias JD, Raman VT. Experience with combining pediatric procedures into a single anesthetic. Pediatr Qual Saf. 2019;4:e207.
Modica PA, Tempelhoff R, White PF. Pro- and anticonvulsant effects of anesthetics (Part I). Anesth Analg. 1990;70:303–15.
Modica PA, Tempelhoff R, White PF. Pro- and anticonvulsant effects of anesthetics (Part II). Anesth Analg. 1990;70:433–44.
Gopalakrishnan S, Sidduiqui S, Mayhew JF. Anesthesia in a child with Batten disease. Paediatr Anaesth. 2004;14:890–1.
Höfler J, Trinka E. Intravenous ketamine in status epilepticus. Epilepsia. 2018;59:198–206.
Jones CT, Raman VT, DeVries S, Cole JW, Kelleher KJ, Tobias JD. Optimizing anticonvulsant administration for children before anesthesia: a quality improvement project. Pediatr Neurol. 2014;51:632–40.
Khaibullina A, Kenyon N, Guptill V, Quezado MM, Wang L, Koziol D, Wesley R, Moya PR, Zhang Z, Saha A, Mukherjee AB, Quezado ZMN. In a model of Batten disease, palmitoyl protein thioesterase-1 deficiency is associated with brown adipose tissue and thermoregulation abnormalities. PLoS ONE. 2012;7:e48733.
Michielsen P, Martin JJ, Vanagt E, Vrints C, Gillebert T, Snoeck J. Cardiac involvement in juvenile ceroid lipofuscinosis of the Spielmeyer–Vogt–Sjogren type: prospective noninvasive findings in two siblings. Eur Neurol. 1984;23:166–72.
Ostergaard JR, Rasmussen TB, Molgaard H. Cardiac involvement in juvenile neuronal ceroid lipofuscinosis (Batten disease). Neurology. 2011;76:1245–51.
Wolf A, Weir P, Segar P, Stone J, Shield J. Impaired fatty acid oxidation in propofol infusion syndrome. Lancet. 2001;357:606–7.
Loh N-HW, Nair P. Propofol infusion syndrome. Cont Educ Anaesth Crit Care Pain. 2013;13:200–2.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflicts of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Yamaguchi, Y., Lyman, R., De Los Reyes, E. et al. Batten disease and perioperative complications: a retrospective descriptive study. J Anesth 34, 342–347 (2020). https://doi.org/10.1007/s00540-020-02747-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00540-020-02747-1